U.S., Australia and Europe are the most attractive destinations outside China for Chinese biopharmas, considering MNC collaboration, clinical trial duration and speed-to-market
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 41 of 58
The slide uses stacked bar charts to show ranking preferences (Top 1, 2, 3) for destinations and simple bar charts for decision factors.
Consulting deck · market_landscape · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 2/2 disclaimer 1/1 legend 1/1 title 2/2
Components 6
bar-horizontal bar-stacked disclaimer legend action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.